DrugPatentWatch Database Preview
Profile for United States of America Patent: 2011008434
US Patent Family Members and Approved Drugs for United States of America Patent: 2011008434
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Aug 9, 2022 | Gilead Sciences Inc | COMPLERA | emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate |
➤ Try a Free Trial | Aug 9, 2022 | Janssen Prods | EDURANT | rilpivirine hydrochloride |
➤ Try a Free Trial | Aug 9, 2022 | Viiv Hlthcare | JULUCA | dolutegravir sodium; rilpivirine hydrochloride |
➤ Try a Free Trial | Aug 9, 2022 | Gilead Sciences Inc | ODEFSEY | emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |